LON:PXS Provexis (PXS) Share Price, News & Analysis → Don’t expose yourself to stocks during the week (From DTI) (Ad) Free PXS Stock Alerts GBX 0.61 -0.04 (-6.31%) (As of 05:52 AM ET) Add Compare Share Share Today's Range 0.60▼ 0.6250-Day Range 0.55▼ 0.7552-Week Range 0.41▼ 0.90Volume545,418 shsAverage Volume851,159 shsMarket Capitalization£13.52 millionP/E Ratio43.75Dividend Yield5.06%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Provexis alerts: Email Address Ad DTIWith the “Bitcoin Loophole” you can supercharge the gains by 10x or moreThanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…Sign up here for a FREE workshop to discover one trader’s $213,000 real-money trade! About ProvexisProvexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.Read More PXS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PXS Stock News HeadlinesMarch 15, 2024 | msn.comPXS Stock Earnings: Pyxis Tankers Beats EPS, Beats Revenue for Q4 2023February 27, 2024 | seekingalpha.comPyxis Tankers: Bet On A Strong MR Product Tankers MarketApril 18, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.January 6, 2024 | finance.yahoo.comWill Provexis (LON:PXS) Spend Its Cash Wisely?December 15, 2023 | uk.investing.comFenbo Holdings Ltd (FEBO)November 17, 2023 | benzinga.comPyxis Tankers's Earnings: A PreviewNovember 9, 2023 | morningstar.comPyxis Tankers Inc PXSSeptember 14, 2023 | finance.yahoo.comPXS.L - Provexis plcApril 18, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.June 28, 2023 | finance.yahoo.comPXS - Pyxis Tankers Inc.April 9, 2023 | finance.yahoo.comProvexis plc (NZCA.F)March 9, 2023 | lse.co.ukDefinition of 'Claims Processing Unit (CPU)'December 30, 2022 | finance.yahoo.comWe're Not Worried About Provexis' (LON:PXS) Cash BurnDecember 1, 2022 | msn.comPyxis Tankers Inc. (PXS) Is a Trending Stock: Facts to Know Before Betting on ItNovember 15, 2022 | seekingalpha.comPyxis Tankers Inc. (PXS) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | msn.comPyxis Tankers Inc. (PXS) Tops Q3 Earnings and Revenue EstimatesOctober 17, 2022 | msn.comPyxis Tankers Inc. (PXS) Gains But Lags Market: What You Should KnowSeptember 22, 2022 | uk.finance.yahoo.comProvexis plc (PXS.L)May 18, 2022 | lse.co.ukBattered stocks inch up; S. African rand falls on power cuts, growth fearsApril 2, 2022 | finance.yahoo.comHere's Why We're Not At All Concerned With Provexis' (LON:PXS) Cash Burn SituationOctober 14, 2021 | nasdaq.comMarket Sentiment Around Loss-Making Pyxis Tankers Inc. (NASDAQ:PXS)October 4, 2021 | finance.yahoo.comWe're Interested To See How Provexis (LON:PXS) Uses Its Cash Hoard To GrowJuly 23, 2021 | markets.businessinsider.comProvexis PLC : Price Monitoring ExtensionSee More Headlines Receive PXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Provexis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/30/2020Today4/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolLON:PXS CUSIPN/A CIKN/A Webwww.provexis.org Phone+44-1753-861777FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio43.75 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net Margins-83.03% Pretax MarginN/A Return on Equity-75.88% Return on Assets-36.73% Debt Debt-to-Equity RatioN/A Current Ratio2.41 Quick Ratio6.21 Sales & Book Value Annual Sales£426,168.00 Price / Sales33.86 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,220,000,000Free FloatN/AMarket Cap£14.43 million OptionableNot Optionable Beta1.24 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Ian Ford BA (Hons) ACA (Age 59)F.C.A., CEO, CFO, Company Secretary & Executive Director Comp: $174.89kDr. Niamh Ann O'Kennedy B.Sc. (Age 51)BSc, M.Sc., MSc, Ph.D., Chief Scientific Officer, Member of Scientific Advisory Board & Executive Director Comp: $99.05kProf. Asim K. Duttaroy BS MS Ph.D.DSc FICN, Consultant & Member of Scientific Advisory BoardKey CompetitorsChill Brands GroupLON:CHLLShield TherapeuticsLON:STXArgent BioPharmaLON:MXCDiurnal GroupLON:DNLVenture Life GroupLON:VLGView All Competitors PXS Stock Analysis - Frequently Asked Questions How have PXS shares performed in 2024? Provexis' stock was trading at GBX 0.65 at the beginning of the year. Since then, PXS stock has decreased by 6.3% and is now trading at GBX 0.61. View the best growth stocks for 2024 here. How were Provexis' earnings last quarter? Provexis plc (LON:PXS) posted its quarterly earnings results on Wednesday, September, 30th. The company reported ($0.02) earnings per share for the quarter. Provexis had a negative trailing twelve-month return on equity of 75.88% and a negative net margin of 83.03%. What other stocks do shareholders of Provexis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Provexis investors own include Taylor Wimpey (TW), ValiRx (VAL), Sirius Minerals (SXX), Lloyds Banking Group (LLOY) and easyJet (EZJ). How do I buy shares of Provexis? Shares of PXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:PXS) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsUrgent alert: open this for a huge profit potentialTimothy SykesBiden out June 13; Kamala won’t replace him?Paradigm PressYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.